152 related articles for article (PubMed ID: 10382099)
21. Peptide and antibody imaging in lung cancer.
Machac J; Krynyckyi B; Kim C
Semin Nucl Med; 2002 Oct; 32(4):276-92. PubMed ID: 12524652
[TBL] [Abstract][Full Text] [Related]
22. Staging and managing lung tumors using F-18 FDG coincidence detection.
Roman MR; Rossleigh MA; Angelides S; Walker BM; Dixon J
Clin Nucl Med; 2001 May; 26(5):383-8. PubMed ID: 11317014
[TBL] [Abstract][Full Text] [Related]
23. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
Higashi K; Nishikawa T; Seki H; Oguchi M; Nambu Y; Ueda Y; Yuasa K; Tonami H; Okimura T; Yamamoto I
J Nucl Med; 1998 Jan; 39(1):9-15. PubMed ID: 9443730
[TBL] [Abstract][Full Text] [Related]
24. Significance of a new fluorodeoxyglucose-positive lesion on restaging positron emission tomography/computed tomography after induction therapy for non-small-cell lung cancer.
Collaud S; Lardinois D; Tischler V; Steinert HC; Stahel R; Weder W
Eur J Cardiothorac Surg; 2012 Mar; 41(3):612-6. PubMed ID: 22219415
[TBL] [Abstract][Full Text] [Related]
25. Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer.
Bury T; Corhay JL; Duysinx B; Daenen F; Ghaye B; Barthelemy N; Rigo P; Bartsch P
Eur Respir J; 1999 Dec; 14(6):1376-80. PubMed ID: 10624770
[TBL] [Abstract][Full Text] [Related]
26. [PET with (18)F-fluorodeoxyglucose for staging of non-small cell lung cancer].
Weber WA; Dietlein M; Hellwig D; Kirsch CM; Schicha H; Schwaiger M
Nuklearmedizin; 2003 Aug; 42(4):135-44. PubMed ID: 12937692
[TBL] [Abstract][Full Text] [Related]
27. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of positron emission tomography in diagnosing and staging of lung cancer].
Zhu ZH; Zhou Q; Li LY; Cui RX; Cheng WY; Li YF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):365-8. PubMed ID: 12940078
[TBL] [Abstract][Full Text] [Related]
29. Value of positron emission tomography for lung cancer staging.
Albes JM; Dohmen BM; Schott U; Schülen E; Wehrmann M; Ziemer G
Eur J Surg Oncol; 2002 Feb; 28(1):55-62. PubMed ID: 11869015
[TBL] [Abstract][Full Text] [Related]
30. [Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000].
Hellwig D; Ukena D; Paulsen F; Bamberg M; Kirsch CM;
Pneumologie; 2001 Aug; 55(8):367-77. PubMed ID: 11505288
[TBL] [Abstract][Full Text] [Related]
31. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.
Kim BT; Lee KS; Shim SS; Choi JY; Kwon OJ; Kim H; Shim YM; Kim J; Kim S
Radiology; 2006 Nov; 241(2):501-9. PubMed ID: 16966480
[TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
33. Quantitative volumetric CT-histogram analysis in N-staging of 18F-FDG-equivocal patients with lung cancer.
Flechsig P; Kratochwil C; Schwartz LH; Rath D; Moltz J; Antoch G; Heussel CP; Rieser M; Warth A; Zabeck H; Kauczor HU; Haberkorn U; Giesel FL
J Nucl Med; 2014 Apr; 55(4):559-64. PubMed ID: 24525209
[TBL] [Abstract][Full Text] [Related]
34. [99mTc]sestamibi and [99mTc]tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors.
Schillaci O; Spanu A; Madeddu G
Q J Nucl Med Mol Imaging; 2005 Jun; 49(2):133-44. PubMed ID: 16010251
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer.
Saunders CA; Dussek JE; O'Doherty MJ; Maisey MN
Ann Thorac Surg; 1999 Mar; 67(3):790-7. PubMed ID: 10215230
[TBL] [Abstract][Full Text] [Related]
36. PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma.
Poncelet AJ; Lonneux M; Coche E; Weynand B; Noirhomme P;
Eur J Cardiothorac Surg; 2001 Sep; 20(3):468-74; discussion 474-5. PubMed ID: 11509265
[TBL] [Abstract][Full Text] [Related]
37. 11C-acetate PET imaging of lung cancer: comparison with 18F-FDG PET and 99mTc-MIBI SPET.
Higashi K; Ueda Y; Matsunari I; Kodama Y; Ikeda R; Miura K; Taki S; Higuchi T; Tonami H; Yamamoto I
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):13-21. PubMed ID: 14574513
[TBL] [Abstract][Full Text] [Related]
38. Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors.
Bombardieri E; Seregni E; Villano C; Chiti A; Bajetta E
Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):150-63. PubMed ID: 15243410
[TBL] [Abstract][Full Text] [Related]
39. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
40. Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules.
Higashi K; Ueda Y; Sakuma T; Seki H; Oguchi M; Taniguchi M; Taki S; Tonami H; Katsuda S; Yamamoto I
J Nucl Med; 2001 Oct; 42(10):1489-96. PubMed ID: 11585862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
